Department of Pathology, University of Alabama at Birmingham.
Department of Endocrinology, University of Alabama at Birmingham.
Am J Clin Pathol. 2020 Feb 8;153(3):342-345. doi: 10.1093/ajcp/aqz164.
We evaluated telecytology rapid on-site evaluation (ROSE) for thyroid ultrasound-guided fine-needle aspiration. To the best of our knowledge, this study is the first case-control clinical trial of thyroid telecytology.
We introduced on-site ROSE in our institution's thyroid clinic for 6 months, followed by telecytology for 12 months. Our institution's ultrasound clinic, where ROSE is not provided, was used as a control group for each period.
Both groups had similar initial unsatisfactory rates (thyroid clinic: 8.8%; ultrasound clinic: 8.0%) before the study began. The thyroid clinic's unsatisfactory rate was significantly reduced to 1.6% after on-site ROSE (P = .001) and to 3.8% after telecytology ROSE (P = .010), with no significant difference between on-site and telecytology ROSE periods (P > .05). The ultrasound clinic's unsatisfactory rate was unchanged for both periods. Concordance between telecytology ROSE and final adequacy was 97% (κ = 0.699).
Telecytology ROSE reduces unsatisfactory rates for ultrasound-guided fine-needle aspiration without compromising patient care.
我们评估了甲状腺超声引导下细针抽吸的远程细胞学即时现场评估（ROSE）。据我们所知，这是首例甲状腺远程细胞学的病例对照临床试验。
我们在本机构的甲状腺诊所引入了现场 ROSE，持续了 6 个月，随后进行了 12 个月的远程细胞学检查。我们机构的超声诊所没有提供 ROSE，作为每个时期的对照组。
在研究开始前，两组的初始不满意率（甲状腺诊所：8.8%；超声诊所：8.0%）相似。在现场 ROSE 后，甲状腺诊所的不满意率显著降低至 1.6%（P=.001），在远程细胞学 ROSE 后降低至 3.8%（P=.010），现场 ROSE 和远程细胞学 ROSE 期间无显著差异（P＞.05）。超声诊所的两个时期的不满意率均无变化。远程细胞学 ROSE 与最终充分性的一致性为 97%（κ=0.699）。
远程细胞学 ROSE 降低了超声引导下细针抽吸的不满意率，同时不影响患者护理。
